Literature DB >> 8034388

Nasal administration of naloxone is as effective as the intravenous route in opiate addicts.

N Loimer1, P Hofmann, H R Chaudhry.   

Abstract

Naloxone is used intravenously in opiate addiction in emergency cases, in rapid opiate detoxification, and as a diagnostic tool. This is a study comparing the efficacy of intranasal naloxone to other routes (intravenous/intramuscular) in 17 opiate-dependent patients. The nasal drug administration of naloxone was found to be as effective as the intravenous route. The nasal drug application offers a wide margin of safety for patients and medical staff, especially in emergency situations in regard to infection risks associated with vessel puncture.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034388     DOI: 10.3109/10826089409047912

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  18 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

3.  Expanding access to naloxone in the United States.

Authors:  Suzanne Doyon; Steven E Aks; Scott Schaeffer
Journal:  J Med Toxicol       Date:  2014-12

4.  Intranasal naltrexone and atipamezole for reversal of white-tailed deer immobilized with carfentanil and medetomidine.

Authors:  Todd K Shury; Nigel A Caulkett; Murray R Woodbury
Journal:  Can Vet J       Date:  2010-05       Impact factor: 1.008

5.  Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.

Authors:  Philip A Krieter; C Nora Chiang; Shwe Gyaw; David J McCann
Journal:  J Clin Pharmacol       Date:  2019-03-12       Impact factor: 3.126

Review 6.  A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Authors:  Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

7.  Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil.

Authors:  Ida Tylleskar; Arne Kristian Skulberg; Sissel Skarra; Turid Nilsen; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2018-08-24       Impact factor: 2.953

Review 8.  Best evidence topic report. Intranasal naloxone in suspected opioid overdose.

Authors:  Helen Ashton; Ziauddin Hassan
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

9.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

Authors:  Maya Doe-Simkins; Alexander Y Walley; Andy Epstein; Peter Moyer
Journal:  Am J Public Health       Date:  2009-05       Impact factor: 9.308

Review 10.  Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Authors:  Jennifer S Orman; Gillian M Keating
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.